Meta-analysis of bioabsorbable versus durable polymer drug-eluting stents in 20,005 patients with coronary artery disease: an update. - Wikidata - awgldk - TriplyDB

Meta-analysis of bioabsorbable versus durable polymer drug-eluting stents in 20,005 patients with coronary artery disease: an update.

Meta-analysis of bioabsorbable versus durable polymer drug-eluting stents in 20,005 patients with coronary artery disease: an update.

http://www.wikidata.org/entity/Q38183346

about

Polymeric Nanostructures for Imaging and Therapy Natural product and natural product derived drugs in clinical trials.Validation of the Ability of SYNTAX and Clinical SYNTAX Scores to Predict Adverse Cardiovascular Events After Stent Implantation: A Systematic Review and Meta-Analysis.Safety and efficacy of a novel abluminal groove-filled biodegradable polymer sirolimus-eluting stent.Third generation drug eluting stent (DES) with biodegradable polymer in diabetic patients: 5 years follow-up.Current State of Bioabsorbable Polymer-Coated Drug-Eluting Stents.Vessel healings after stenting with different polymers in STEMI patients.Safety and efficacy profile of bioresorbable-polylactide-polymer-biolimus-A9-eluting stents versus durable-polymer-everolimus- and zotarolimus-eluting stents in patients with acute coronary syndrome.One-year outcome from an all-comers population of patients with ST-segment elevation myocardial infarction treated with biolimus-eluting stent with biodegradable polymer.Biodegradable polymer drug-eluting stents versus first-generation durable polymer drug-eluting stents: A systematic review and meta-analysis of 12 randomized controlled trials.Orsiro cobalt-chromium sirolimus-eluting stent: present and future perspectives.Should ultrathin strut drug eluting stents be considered the new benchmark for novel coronary stents approval? The complex interplay between stent strut thickness, polymeric carriers and antiproliferative drugs.Current State of Bioabsorbable Polymer-Coated Drug-Eluting Stents.

P2860

Q30372383-F8553755-5663-47CF-B991-15B632872A91 Q38247457-EF851B8B-4761-4062-AD4B-94FF18840D3F Q38651229-9478A434-8EFA-4F80-924A-1B5F64AB317A Q38961196-B9F4577F-538B-46FB-9CD2-7E2063BCE177 Q38969182-14317E86-B893-4F56-A43F-7ADB5DEC5BAD Q39053571-C05A1328-517C-4075-817E-62C367332525 Q39611182-275BDC38-70BD-4050-A802-C7CEC32FCC7C Q39632788-D572809A-30DD-43DF-8714-0E6B015B9F1C Q46002346-F0C98601-BBBE-4FE3-AE0E-DD24B9E205E7 Q47302287-D5D7732A-A586-49E9-AA6B-2E44BFC5AB4A Q47956360-D4812FDA-A903-44B0-8E19-D0BEA0F04E7E Q52334995-8C5E61A9-4CEF-48CA-98EC-1C5F59CE92F6 Q54960240-AFBEEA68-CBB9-4E3D-AC40-AC89C19FF8DE

P2860

Meta-analysis of bioabsorbable versus durable polymer drug-eluting stents in 20,005 patients with coronary artery disease: an update.

http://www.wikidata.org/entity/Q38183346

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Meta-analysis of bioabsorbable ...... ary artery disease: an update.

@en

type

label

Meta-analysis of bioabsorbable ...... ary artery disease: an update.

@en

prefLabel

Meta-analysis of bioabsorbable ...... ary artery disease: an update.

@en

P1433

Q38183346-0157D5EF-93C6-4A92-A554-2D1CE5AD7262

P1476

Q38183346-F8125215-22BD-49D8-99D4-2DDD715B3C79

P2093

Q38183346-13A8FA3A-6B6F-4C75-B50D-D952C50169F7

Q38183346-2C59789B-7EF8-4E64-A0B3-E0A724E4771A

Q38183346-3F55FA0A-AE33-45E3-92AF-CF6893C79BC0

Q38183346-8F4405E3-97CE-48B5-A02A-F59B153277AC

Q38183346-9F7B4664-BA90-40A7-AC5E-1114023BC23B

Q38183346-BB0EE572-BD5C-447E-B526-F5BC31AD95B5

Q38183346-BC4930B0-AEC0-45AA-BBEC-E6D5261A3C28

Q38183346-BF9BDC80-E15E-40AD-A794-7E9FB3EC6B34

Q38183346-CC602949-E342-4786-9E4A-6B00CF91A51B

P2860

Q38183346-09BE283B-6704-4642-85FD-15B08D09F7BB

Q38183346-0D67831C-56C1-4A2A-88AA-D72FEE33C032

Q38183346-1DB6F71A-065C-4A14-BFF5-B7FE1517D2AE

Q38183346-1F97C83B-A8FB-4E8C-BA47-16CA669237EF

Q38183346-212AA317-AE04-4E3A-B270-706385240BE5

Q38183346-237A0184-5B39-4407-A093-7974BD4DDDC2

Q38183346-3DDAAC90-DDA4-4D8B-996A-8E99DC20A247

Q38183346-4323990E-F19D-4ABE-A12C-58E66009ADE4

Q38183346-4923E12B-70FD-40A6-83ED-4D610C1E41E2

Q38183346-4ED67F58-6D17-45F6-BE58-AAB5071E08CC

P304

Q38183346-29A2943C-15C2-4053-A068-8A4259CA6B95

P31

Q38183346-6aeb0503-ac60-4722-b15c-7a987529a0bc

Q38183346-BF638E0B-D5FC-4D40-B0E0-950EA2FEA67F

P356

Q38183346-580A61A5-979C-4CD5-9D9B-02222BDE3CCC

P433

Q38183346-A2FF8B3C-BE75-4D77-AEA8-FF629F9F4AD4

P478

Q38183346-9ECDFF30-645B-4932-86A7-695F4CFCB5FE

P50

Q38183346-6DCC3E88-D8B8-424C-BA8A-64703324C6BE

P577

Q38183346-0B833FD1-2F59-43B3-9D0A-67611FEED3AA

P5875

Q38183346-D177046E-7C18-41E0-A2BF-DC71177BC618

P698

Q38183346-B5DF48B2-6503-4E76-8DFB-0C8F3E5951BB

P356

P1433

Catheterization and Cardiovascular Interventions

P1476

Meta-analysis of bioabsorbable ...... nary artery disease: an update

@en

P2093

Alessandro Lupi

http://www.w3.org/2001/XMLSchema#string

Andrea Rognoni

http://www.w3.org/2001/XMLSchema#string

Angelo Sante Bongo

http://www.w3.org/2001/XMLSchema#string

Gioel Gabrio Secco

http://www.w3.org/2001/XMLSchema#string

Imad Sheiban

http://www.w3.org/2001/XMLSchema#string

Italo Porto

http://www.w3.org/2001/XMLSchema#string

Leonardo Bolognese

http://www.w3.org/2001/XMLSchema#string

Maurizio Lazzero

http://www.w3.org/2001/XMLSchema#string

Rossella Fattori

http://www.w3.org/2001/XMLSchema#string

P2860

Bias in meta-analysis detected by a simple, graphical test

Measuring inconsistency in meta-analyses

Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization

A novel bioresorbable polymer paclitaxel-eluting stent for the treatment of single and multivessel coronary disease: primary results of the COSTAR (Cobalt Chromium Stent With Antiproliferative for Restenosis) II study.

Biodegradable polymer drug-eluting stents reduce the risk of stent thrombosis at 4 years in patients undergoing percutaneous coronary intervention: a pooled analysis of individual patient data from the ISAR-TEST 3, ISAR-TEST 4, and LEADERS randomize

Hypersensitivity cases associated with drug-eluting coronary stents: a review of available cases from the Research on Adverse Drug Events and Reports (RADAR) project.

Analysis of data from multiclinic trials.

Clinical end points in coronary stent trials: a case for standardized definitions.

Bare metal stents, durable polymer drug eluting stents, and biodegradable polymer drug eluting stents for coronary artery disease: mixed treatment comparison meta-analysis.

Stents as a platform for drug delivery.

P304

E193-206

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/CCD.25416

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

83

http://www.w3.org/2001/XMLSchema#string

P50

Pierfrancesco Agostoni

P577

2014-02-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

259986045

http://www.w3.org/2001/XMLSchema#string

P698

24478247

http://www.w3.org/2001/XMLSchema#string